Oya Kerımoğlu
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Dermatology top 5%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Papers in
-
- Advancements in Transdermal Drug Delivery 7
- Advanced Drug Delivery Systems 5
-
- Electrospun Nanofibers in Biomedical Applications 2
- Co-authors
- Yusuf K. Demir (3 shared papers)Zafer Akan (2 shared papers)Emıne Alarçın (5 shared papers)Hüseyın Karagöz (2 shared papers)Ersın Ülkür (2 shared papers)Dilek Akakın (2 shared papers)Betül Dortunç (3 shared papers)Seher Karslı-Çeppioğlu (1 shared paper)
- Journals
- PLoS ONE (2 papers)Microsurgery (2 papers)International Journal of Biological Macromolecules (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)Drug Development Research (1 paper)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
Oya Kerımoğlu
14 papers receiving 315 citations
Peers
Comparison fields: 5 of 67
- Pharmaceutical Science 218
- Dermatology 100
- Insect Science 38
- Molecular Medicine 12
- Biomaterials 28
Countries citing papers authored by Oya Kerımoğlu
This map shows the geographic impact of Oya Kerımoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oya Kerımoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oya Kerımoğlu more than expected).
Fields of papers citing papers by Oya Kerımoğlu
This network shows the impact of papers produced by Oya Kerımoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oya Kerımoğlu. The network helps show where Oya Kerımoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Oya Kerımoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 135 | |
| 2 | 2013 | 59 | |
| 3 | 2012 | 28 | |
| 4 | 2015 | 17 | |
| 5 | 2012 | 16 | |
| 6 | 2015 | 16 | |
| 7 | 2020 | 10 | |
| 8 | Pyometra in elderly post-menopausal women: a sign of malignity. | 2015 | 10 |
| 9 | 2025 | 7 | |
| 10 | 2017 | 7 | |
| 11 | Animal Skin Models for Percutaneous Absorption Studies | 2018 | 4 |
| 12 | 2015 | 3 | |
| 13 | Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization. | 2013 | 3 |
| 14 | PHARMACODYNAMICAL EVALUATION OF MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING CAPTOPRIL. | 2016 | 2 |
About Oya Kerımoğlu
Oya Kerımoğlu is a scholar working on Pharmaceutical Science, Biomaterials, Cellular and Molecular Neuroscience, Dermatology and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 317 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (5 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), Nerve injury and regeneration (2 papers), Ocular Surface and Contact Lens (2 papers), Dermatology and Skin Diseases (2 papers), Diabetes Management and Research (1 paper) and Contact Dermatitis and Allergies (1 paper). The work is most often cited by research in Pharmaceutical Science (218 citations), Dermatology (100 citations), Insect Science (38 citations), Molecular Medicine (12 citations) and Biomaterials (28 citations). Oya Kerımoğlu has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Yusuf K. Demir, Zafer Akan, Emıne Alarçın, Hüseyın Karagöz, Ersın Ülkür, Dilek Akakın, Betül Dortunç, Seher Karslı-Çeppioğlu, Ayça Bal‐Öztürk and Çiğdem Çelik. Their work appears in journals such as PLoS ONE, Microsurgery, International Journal of Biological Macromolecules, Chemical and Pharmaceutical Bulletin and Drug Development Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.